Comments to “Is epileptogenesis a key to treatment of childhood epileptic encephalopathies?”

Publications

Share / Export Citation / Email / Print / Text size:

Journal of Epileptology

Foundation of Epileptology

Subject: Medicine

GET ALERTS

eISSN: 2300-0147

DESCRIPTION

4
Reader(s)
4
Visit(s)
0
Comment(s)
0
Share(s)

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue / page

Archive
Related articles

VOLUME 23 , ISSUE 2 (December 2015) > List of articles

Comments to “Is epileptogenesis a key to treatment of childhood epileptic encephalopathies?”

Elena Belousova *

Citation Information : Journal of Epileptology. Volume 23, Issue 2, Pages 89-90, DOI: https://doi.org/10.1515/joepi-2015-0028

License : (CC BY 4.0)

Received Date : 12-November-2015 / Published Online: 24-November-2015

ARTICLE

ABSTRACT

Content not available PDF Share

FIGURES & TABLES

REFERENCES

Boerma R.S., Braun K.P., van den Broek M.P., van Berkestijn F.M., Swinkels M.E., Hagebeuk E.O. et al.: Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach. Neurotherapeutics, 2015, Aug. 22. [Epub ahead of print].

 

Zhang B., McDaniel S.S., Rensing N.R., Wong M.: Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. PLoS One, 2013, 8: e57445.

 

EXTRA FILES

COMMENTS